Ibuprofen PM (Diphenhydramine Citrate, Ibuprofen)

WR Group, Inc. · tablet, coated · NDC 69607-1970

Listed in the FDA National Drug Code directory

Ibuprofen PM is an over-the-counter medicine made available by WR Group, Inc., on the U.S. market since February 2025. It is marketed under an FDA approval (ANDA ANDA211404), so the FDA has reviewed its safety, effectiveness and manufacturing. A listing proves the product exists; it does not prove that a particular pack is genuine, so compare yours with the official description below.

What the genuine product looks like

From the official FDA label (version of Mar 25, 2025). Compare the colour, shape, imprint and packaging with what you have. Any difference is a reason to ask a pharmacist before taking it.

Product data on the label: Ibuprofen PM Diphenhydramine Citrate, Ibuprofen IBUPROFEN IBUPROFEN DIPHENHYDRAMINE CITRATE DIPHENHYDRAMINE CARNAUBA WAX STARCH, CORN CROSCARMELLOSE SODIUM FD&C BLUE NO. 2 HYPROMELLOSE, UNSPECIFIED CELLULOSE, MICROCRYSTALLINE POLYDEXTROSE POLYETHYLENE GLYCOL 400 SILICON DIOXIDE STEARIC ACID TITANIUM DIOXIDE PL72 Oblong

Text on the package panel: Principal Display Panel †Compare to the active ingredients in Advil® PM Ibuprofen PM Ibuprofen 200 mg Pain reliever (NSAID)* Diphenhydramine citrate 38 mg Nighttime sleep-aid Coated caplets** (**Capsules-shaped tablets) †This product is not manufactured or distributed by Haleon Group of Companies distributor Advil® PM TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING. KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION. Distributed by: Kolbe & Schmitt®…

What it is for

Purpose Nighttime sleep-aid Pain Reliever

Key warnings

Warnings Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: hives facial swelling asthma (wheezing) shock skin reddening rash blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you: are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs…

Excerpts from the FDA label. Always read the leaflet in your pack and ask a pharmacist or doctor about your own situation.

Advertisement

Recalls of this product

No FDA recalls are recorded for NDC 69607-1970. Recalls are listed in FDA enforcement reports from 2004 onward.

Most reported side effects for diphenhydramine citrate, ibuprofenReports to the FDA Adverse Event Reporting System (FAERS), all products with this ingredient
Fatigue8 reports
Nausea8 reports
Completed suicide5 reports
Abdominal distension4 reports
Diarrhoea4 reports
Hypoaesthesia4 reports
Insomnia4 reports
Joint swelling4 reports
Product use in unapproved indication4 reports
Vomiting4 reports
Show as table
ItemValue (reports)
Fatigue8
Nausea8
Completed suicide5
Abdominal distension4
Diarrhoea4
Hypoaesthesia4
Insomnia4
Joint swelling4
Product use in unapproved indication4
Vomiting4

These counts are reports, not proof that the medicine caused the problem. Popular medicines get more reports simply because more people take them. They are useful for spotting what to watch for, not for comparing medicines.

Official listing

Brand
Ibuprofen PM
Generic name
Diphenhydramine Citrate, Ibuprofen
Company
WR Group, Inc.
Form
tablet, coated
Route
oral
Type
HUMAN OTC DRUG
Category
ANDA
Listing valid to
Dec 31, 2027
Product NDC
69607-1970

Active ingredients

Ibuprofen
200 mg/1
Diphenhydramine Citrate
38 mg/1

Packages (1)

The last part of the NDC identifies the pack size. Your box should show one of these.

69607-1970-1 1 bottle, plastic in 1 box (69607-1970-1) / 120 tablet, coated in 1 bottle, plastic

Think your pack is fake?

Stop taking it, keep the pack and receipt, and show it to a pharmacist. In the U.S., report it to FDA MedWatch; elsewhere, to your national medicines regulator. How to spot a fake medicine.

Source: openFDA (U.S. Food and Drug Administration) drug directory, labels, enforcement reports and FAERS, retrieved Nov 8, 2026. The FDA notes this data should not be relied on alone for medical decisions. Not medical advice.